Descovy
USPSTF Gives ‘A’ Rating to All 3 Approved PrEP Medications, but Access Challenges Remain
In addition to Truvada, the new recommendations also include the daily oral drug Descovy and the long-acting ...
SEPTEMBER 6, 2023
High Rates of PrEP Adherence and Persistence for F/TAF Patients
Patients who are naive to HIV PrEP and prescribed Descovy (Gilead) have a greater number of prescription dispenses, ...
JANUARY 6, 2023
FDA Advisory Committee Endorses Descovy for PrEP for MSM
While most of the committee (16-2) agreed that Gilead provided substantial evidence for the safety and ...
AUGUST 7, 2019
Good Virologic Response Seen for Bictegravir in HIV
News from CROI 2017: Gilead's novel, investigational drug appears to be promising in rapidly suppressing HIV.
FEBRUARY 15, 2017
Load more